Par Pharmaceutical Receives Final Approval To Market Tretinoin Capsules

WOODCLIFF LAKE, N.J., Oct. 25, 2012 — /PRNewswire/ —┬áPar Pharmaceutical Companies, Inc. today announced that its operating subsidiary, Anchen Pharmaceuticals, Inc., has received final approval from the U.S. Food and Drug Administration for …

Share